India is among the top two countries in terms of type 2 diabetes cases and third in terms of obesity; hence, the need for ...

I hear a lot of talk around our small town when someone becomes noticeably thinner. “He sure has lost a lot of weight.” “Did ...

On Instagram Stories, Roxy Jacenko dropped a photo of herself in a White Fox sky blue dress. The outfit featured sequins and star appliqués. The 44-year-old businesswoman wrote that her daughter was ...

Julio César Chávez Jr., son of boxing legend, was detained by immigration authorities over visa issues, criminal charges and ...

MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...

Both well-established and small, clinical-stage pharma companies are investing heavily to be able to someday compete with ...

Mr. Abraham used his fortune to donate to super PACS supporting Democrats and to efforts to bring peace to the Middle East.

I’m so happy and proud of what I’ve done and no one can take that away from me,” she captioned the side-by-side mirror ...

Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...

Ozempic could help with his as a study by Goldman Sachs found that the mass-adoption of GLP-1 series drugs could allow for ...

VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.